Ambrx Biopharma

YTD

ALL

Why Robinhood?

You can watch AMAM and buy or sell other stocks, ETFs, and their options commission-free!

About AMAM

Ambrx Biopharma, Inc. is a clinical-stage biologics company, which engages in discovering and developing a novel class of engineered precision biologics (EPBs). Using its proprietary expanded genetic code technology platform, it allows incorporating synthetic amino acids (SAAs) into proteins within living cells.

CEO

Daniel J. O'Connor

CEODaniel J. O'Connor

Employees

—

Employees—

Headquarters

La Jolla, California

HeadquartersLa Jolla, California

Founded

2023

Founded2023

Employees

—

Employees—

AMAM Key Statistics

Market cap

1.77B

Market cap1.77B

Price-Earnings ratio

-13.86

Price-Earnings ratio-13.86

Dividend yield

—

Dividend yield—

Average volume

311.84K

Average volume311.84K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$28.15

52 Week high$28.15

52 Week low

$6.55

52 Week low$6.55

People also own

Based on the portfolios of people who own AMAM. This list is generated using Robinhood data, and it’s not a recommendation.

C3.AI

Palantir Technologies